Lucy Scientific Discovery Signs Definitive Agreement To Acquire Wesana Health; No Financial Terms Disclosed
Lucy Scientific Discovery Signs Definitive Agreement To Acquire Wesana Health; No Financial Terms Disclosed
露西科學發現簽署收購威塞納健康的最終協議;沒有披露任何財務條款
Lucy Scientific Discovery CEO Chris McElvany and Wesana CEO Dan Carcillo joined Steve Darling from Proactive to share news the company has signed a definitive agreement to purchase the assets of Wesana Health.
露西科學發現首席執行官克里斯·麥克爾瓦尼和韋斯娜首席執行官丹·卡爾卡里洛加入了史蒂夫·達令從積極分享新聞,該公司已簽署了購買威塞納健康資產的最終協議。
McElvany tells Proactive more about the decision to acquire the company and more specifically about its psilocybin and CBD combination investigational therapy, SANA-013.
麥克爾瓦尼告訴主動更多關於收購該公司的決定,更具體地介紹其裸蓋菇鹼和 CBD 組合研究治療, SANA-013.
Carcillo talks more about SANA-013 and the works they have been doing. He also talks about what his role will be on the Lucy management team.
卡爾卡里洛更多地談論 SANA-013 和他們一直在做的工作。他還談到了他在 Lucy 管理團隊中的角色。